(Q40700694)

22 September 2017

title

Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older (English)

1 reference

22 September 2017

1 reference

Williams B

1

1 reference

22 September 2017

Noonan G

2

1 reference

22 September 2017

Reiss TF

3

1 reference

22 September 2017

Knorr B

4

1 reference

22 September 2017

Guerra J

5

1 reference

22 September 2017

White R

6

1 reference

22 September 2017

Matz J

7

1 reference

22 September 2017

publication date

1 June 2001

1 reference

Clinical & Experimental Allergy

22 September 2017

published in

1 reference

22 September 2017

volume

31

1 reference

22 September 2017

issue

6

1 reference

22 September 2017

page(s)

845-854

1 reference

Relative safety and efficacy of inhaled corticosteroids

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01085.X

Effects of montelukast (MK-0476), a new potent cysteinyl leukotriene (LTD4) receptor antagonist, in patients with chronic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01085.X

Effects of 6 weeks of therapy with oral doses of ICI 204,219, a leukotriene D4 receptor antagonist, in subjects with bronchial asthma. ACCOLATE Asthma Trialists Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01085.X

Treatment of asthma with drugs modifying the leukotriene pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01085.X

Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01085.X

Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01085.X

Leukotriene-receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01085.X

Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01085.X

Measuring quality of life in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01085.X

Leukotrienes are potent constrictors of human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01085.X

10.1046/J.1365-2222.2001.01085.X

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference